Literature DB >> 7820650

(2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl) glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices.

A A Genazzani1, M R L'Episcopo, G Casabona, H Shinozaki, F Nicoletti.   

Abstract

In rat hippocampal slices, the novel metabotropic glutamate receptor (mGluR) ligand, (1S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine (DCG-IV) enhanced the stimulation of polyphosphoinositide (PPI) hydrolysis elicited by quisqualate or by submaximal concentrations of ibotenate or (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD). The enhancing effect of DCG-IV was (i) specific for mGluR agonists, (ii) restricted to hippocampal slice preparation, (iii) reversible, and (iv) not subject to homologous desensitization, in addition, DCG-IV did not interact with L-2-amino-4-phosphonobutanoate (AP4), a noncompetitive antagonist of mGluRs coupled to PPI hydrolysis in brain slices [32]. The action of DCG-IV on quisqualate-stimulated PPI hydrolysis was insensitive to antagonists of ionotropic glutamate receptors and did not appear to be a consequence of a reduction in the intracellular levels of cAMP [14]. When the stimulation of PPI hydrolysis was measured as a function of the incubation time, DCG-IV potentiated quisqualate-stimulated PPI hydrolysis after 60 min of incubation, when quisqualate had already reached its maximal effect. Knowing that activation of protein kinase C (PKC) limits the extent of mGluR agonist-stimulated PPI hydrolysis over time, we have studied the enhancing effect of DCG-IV in the presence of the PKC activator, 12-O-tetradecanoylphorbol-13-acetate (TPA). As expected [9], TPA reduced quisqualate-stimulated PPI hydrolysis in control slices, but was inactive in slices incubated in the presence of DCG-IV. Taken collectively, these results suggest that DCG-IV positively modulates the activity of mGluRs coupled to PPI hydrolysis through a mechanism, which involves PKC-mediated phosphorylation processes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7820650     DOI: 10.1016/0006-8993(94)90857-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Partners for adenosine A1 receptors.

Authors:  Rafael Franco; Francisco Ciruela; Vicent Casadó; Antonio Cortes; Enric I Canela; Josefa Mallol; Luigi F Agnati; Sergi Ferré; Kjell Fuxe; Carmen Lluis
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 2.  Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins.

Authors:  R Franco; C Lluis; E I Canela; J Mallol; L Agnati; V Casadó; F Ciruela; S Ferré; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

3.  GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity.

Authors:  Ajit G Thomas; Amos Bodner; Ghanashyam Ghadge; Raymond P Roos; Barbara S Slusher
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

Review 4.  Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+.

Authors:  Tim D Werry; Graeme F Wilkinson; Gary B Willars
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

5.  Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta.

Authors:  V Bruno; G Battaglia; G Casabona; A Copani; F Caciagli; F Nicoletti
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

6.  Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.

Authors:  Luisa Di Menna; Max E Joffe; Luisa Iacovelli; Rosamaria Orlando; Craig W Lindsley; Jèrome Mairesse; Pierre Gressèns; Milena Cannella; Filippo Caraci; Agata Copani; Valeria Bruno; Giuseppe Battaglia; P Jeffrey Conn; Ferdinando Nicoletti
Journal:  Neuropharmacology       Date:  2017-10-25       Impact factor: 5.250

Review 7.  Metabotropic glutamate receptors: from the workbench to the bedside.

Authors:  F Nicoletti; J Bockaert; G L Collingridge; P J Conn; F Ferraguti; D D Schoepp; J T Wroblewski; J P Pin
Journal:  Neuropharmacology       Date:  2010-10-29       Impact factor: 5.250

8.  Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats.

Authors:  Anna Rita Zuena; Jerome Mairesse; Paola Casolini; Carlo Cinque; Giovanni Sebastiano Alemà; Sara Morley-Fletcher; Valentina Chiodi; Luigi Giusto Spagnoli; Roberto Gradini; Assia Catalani; Ferdinando Nicoletti; Stefania Maccari
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

9.  Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia.

Authors:  Francesco Fazio; Luana Lionetto; Martina Curto; Luisa Iacovelli; Michele Cavallari; Cristina Zappulla; Martina Ulivieri; Flavia Napoletano; Matilde Capi; Valentina Corigliano; Sergio Scaccianoce; Alessandra Caruso; Jessica Miele; Antonio De Fusco; Luisa Di Menna; Anna Comparelli; Antonella De Carolis; Roberto Gradini; Robert Nisticò; Antonio De Blasi; Paolo Girardi; Valeria Bruno; Giuseppe Battaglia; Ferdinando Nicoletti; Maurizio Simmaco
Journal:  Sci Rep       Date:  2015-12-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.